Akebia Therapeutics
AKBA
#7041
Rank
NZ$0.67 B
Marketcap
$3.12
Share price
1.68%
Change (1 day)
90.51%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$1.07

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.10. In 2022 the company made an earnings per share (EPS) of -$0.87 an increase over its 2021 EPS that were of -$2.91.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.0722.64%
2022-$0.87-70%
2021-$2.91-38.63%
2020-$4.7417.37%
2019-$4.042.79%
2018-$3.9331.2%
2017-$3.00-51.39%
2016-$6.1657.89%
2015-$3.90-94.83%
2014-$75.50589.75%
2013-$10.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.22-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.40-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$24.11-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.79 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA